PRESS RELEASE published on 04/17/2026 at 21:00, 1 month 10 days ago Informations privilégiées / Autres communiqués Innate Pharma présentera des résultats intermédiaires de l'essai de Phase 2 MATISSE évaluant IPH5201 lors d'une session plénière dédiée aux essais cliniques au congrès de l'AACR 2026 Essai Clinique Cancer Du Poumon Innate Pharma AACR 2026 IPH5201
PRESS RELEASE published on 04/17/2026 at 21:00, 1 month 10 days ago Inside Information / Other news releases Innate Pharma to present interim results of IPH5201 in MATISSE Phase 2 study at AACR 2026. Study aims to enhance NSCLC treatment with anti-CD39 monoclonal antibody NSCLC Innate Pharma AACR 2026 MATISSE Phase 2 IPH5201
BRIEF published on 04/13/2026 at 07:05, 1 month 15 days ago Innate Pharma Updates Share and Voting Rights as of April 2026 Biotechnology Shares And Voting Rights Innate Pharma April 2026 Euronext Nasdaq
BRIEF published on 04/13/2026 at 07:05, 1 month 15 days ago Innate Pharma : Mise à Jour du Capital et des Droits de Vote Droits De Vote Biotechnologie Actions Immunothérapie Innate Pharma
BRIEF published on 04/13/2026 at 07:05, 1 month 15 days ago Innate Pharma met à jour ses actions et ses droits de vote à compter d'avril 2026 Biotechnologie Innate Pharma Actions Et Droits De Vote Avril 2026 Euronext Nasdaq
BRIEF published on 04/13/2026 at 07:05, 1 month 15 days ago Innate Pharma: Capital and Voting Rights Update Voting Rights Biotechnology Actions Immunotherapy Innate Pharma
PRESS RELEASE published on 04/13/2026 at 07:00, 1 month 15 days ago Informations privilégiées / Autres communiqués Innate Pharma a publié le nouveau nombre d'actions et de droits de vote au 9 avril 2026 conformément aux règlements de l'AMF. Découvrez les détails dans le communiqué de presse Droits De Vote Actions AMF Communiqué De Presse Innate Pharma
PRESS RELEASE published on 04/13/2026 at 07:00, 1 month 15 days ago Inside Information / Other news releases Innate Pharma to hold its Annual General Meeting of shareholders on May 21, 2026 at 10:30 a.m. CEST in Marseille. Shareholders must register shares by May 14, 2026, 00:00 Paris time, to attend Annual General Meeting Shareholders Registration Innate Pharma Marseille
PRESS RELEASE published on 04/13/2026 at 07:00, 1 month 15 days ago Inside Information / Other news releases Innate Pharma releases total shares and voting rights as of April 9, 2026, in compliance with French regulations. Learn about its innovative immunotherapies for cancer patients Voting Rights Shares French Regulations Innate Pharma Immunothérapies
BRIEF published on 04/03/2026 at 07:05, 1 month 25 days ago Innate Pharma to Join Kempen Life Sciences Conference Biotechnology Investor Meetings Innate Pharma Cancer Immunotherapies Kempen Conference
Published on 05/28/2026 at 08:00, 1 hour 6 minutes ago Touchstone Exploration Provides An Operational Update
Published on 05/28/2026 at 01:15, 7 hours 51 minutes ago JM Capital II Corp. Announces Departure of President, Chief Financial Officer and Chief Financial Officer Jay Freeman
Published on 05/28/2026 at 00:55, 8 hours 11 minutes ago First Helium Closes Oversubscribed $2.6 Million Placement
Published on 05/27/2026 at 23:42, 9 hours 24 minutes ago New Horizon Aircraft Ltd. Announces Closing of $25 Million Offering of Common Shares
Published on 05/28/2026 at 08:05, 1 hour 1 minute ago Hyundai Mobis Adopts Open Source for Mobility Software Development… Driving the Establishment of a Global Standard Platform!
Published on 05/28/2026 at 08:00, 1 hour 6 minutes ago KAP AG BEGINS THE NEW FINANCIAL YEAR IN LINE WITH EXPECTATIONS AND REAFFIRMS ITS GUIDANCE FORECAST FOR 2026
Published on 05/28/2026 at 08:00, 1 hour 6 minutes ago Adler Group S.A. announces results for 3M 2026 demonstrating progress with development disposals and solid performance
Published on 05/28/2026 at 07:30, 1 hour 36 minutes ago EVN AG: Business development in the first half of 2025/26
Published on 05/28/2026 at 08:45, 21 minutes ago Appointment of Mikael Frenkian as Chief Executive Officer of Baikowski
Published on 05/28/2026 at 08:45, 21 minutes ago Nomination de Mikael Frenkian en qualité de Directeur Général de Baikowski
Published on 05/28/2026 at 08:30, 36 minutes ago Cegedim Business Services renforce sa conformité et sa sécurité avec deux distinctions majeures
Published on 05/27/2026 at 23:00, 10 hours 6 minutes ago BIOPHYTIS MODIFIE SA LIGNE DE FINANCEMENT AVEC HEXAGON CAPITAL FUND POUR RENDRE RENOUVELABLE SA CAPACITE DE TIRAGE DE 2M€
Published on 05/27/2026 at 23:00, 10 hours 6 minutes ago BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
